| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | WO1998007408A1 Novel liposome complexes for increased systemic delivery |
| 02/26/1998 | WO1998003669A3 Vectors for inhibiting hiv and tumor growth |
| 02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997049807A3 A novel hypertension related calcium regulated gene (hcarg) |
| 02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
| 02/26/1998 | DE19633698A1 Neue Systeme zur Regulation der Genexpression New systems for the regulation of gene expression |
| 02/26/1998 | CA2269654A1 Long-term expression of gene products by transforming muscle cells |
| 02/26/1998 | CA2264205A1 Use of flexible plastic tanks in gene therapy |
| 02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263189A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0824918A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-$g(k)B |
| 02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |
| 02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824362A1 Biosynthetic virus vectors for gene therapy |
| 02/25/1998 | EP0824361A1 Stable virus packaging cell lines |
| 02/25/1998 | CN1174572A Human tissue inhibitor of metalloproteinase -4 |
| 02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
| 02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
| 02/25/1998 | CN1174506A Method of immunomodulation by means of adoptive transfer of antigernspecific cytotoxic T-cells |
| 02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721340 p53 proteins with altered tetramerization domains |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721218 Antibody therapy |
| 02/24/1998 | US5721215 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/23/1998 | CA2183901A1 Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans |
| 02/19/1998 | WO1998006864A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | WO1998006847A1 Human dbi/acbp-like protein |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006842A1 Mammalian cell surface antigens; related reagents |
| 02/19/1998 | WO1998006841A2 Two human nsp-like proteins |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006753A2 P53 mutant |
| 02/19/1998 | WO1998006746A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006389A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
| 02/19/1998 | WO1997041243A3 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene |
| 02/19/1998 | WO1997039120A3 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
| 02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
| 02/19/1998 | DE19707497A1 Reaktionsbeutelvorrichtung zur Durchführung von mehrstufigen Kultivierungs/Separations-Vorgängen und/oder Reaktionen Reaction bag apparatus for performing multi-step culturing / separation processes and / or reactions |
| 02/19/1998 | CA2263706A1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263172A1 Two human nsp-like proteins |
| 02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
| 02/19/1998 | CA2263165A1 Human induced tumor protein |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/17/1998 | US5719131 Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
| 02/17/1998 | US5719055 Insertion of dna into host gene; genetic engineering |
| 02/12/1998 | WO1998005790A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof |
| 02/12/1998 | WO1998005786A2 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | WO1998005774A1 Use of a human vascular endothelial cell growth factor gene for direct genetic therapy |
| 02/12/1998 | WO1998005768A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
| 02/12/1998 | WO1998005678A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 02/12/1998 | WO1998005356A1 NOVEL FtsL |
| 02/12/1998 | WO1998005352A1 Hypothalamus-specific polypeptides |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005344A1 Bacteriophage-mediated gene therapy |
| 02/12/1998 | WO1998005304A1 Biocompatible devices with foam scaffolds |
| 02/12/1998 | WO1998000544A3 Growth arrest gene compositions and methods |
| 02/12/1998 | WO1997047271A3 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 02/12/1998 | CA2262624A1 A novel method of detecting and treating cancer |
| 02/12/1998 | CA2262517A1 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | CA2262415A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2261565A1 Hypothalamus-specific polypeptides |
| 02/12/1998 | CA2233705A1 Improved nucleic acids encoding a chimeric glycosyltransferase |